Migraine is a neurological disorder characterized by recurrent, severe headaches often accompanied by nausea, vomiting, and sensitivity to light and sound. Attacks can last 4–72 hours and significantly impair daily functioning.
Sumatriptan is a triptan used to treat acute migraine attacks by selectively constricting cranial blood vessels and inhibiting pain pathways.
Rizatriptan is a triptan used to treat acute migraine attacks by selectively constricting cranial blood vessels and inhibiting pain pathways.
Zolmitriptan is a triptan used to treat acute migraine attacks by selectively constricting cranial blood vessels and inhibiting pain pathways.
Naratriptan is a triptan used to treat acute migraine attacks by selectively constricting cranial blood vessels and inhibiting pain pathways.
Eletriptan is a triptan used to treat acute migraine attacks by selectively constricting cranial blood vessels and inhibiting pain pathways.
Frovatriptan is a triptan used to treat acute migraine attacks by selectively constricting cranial blood vessels and inhibiting pain pathways.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: